Cornerstone Financial Management’s BioAge Labs BIOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$780 Hold
110
– – ﹤0.01% 1262
2026
Q2
$2.7K Hold
110
– – ﹤0.01% 757
2026
Q1
$1.92K Hold
110
– – ﹤0.01% 751
2025
Q4
$1.46K Buy
+110
New +$975 ﹤0.01% 793

Other funds holding BIOA

Cornerstone Financial Management's BIOA Position: Q3 2026 in Review

Cornerstone Financial Management held its BioAge Labs (BIOA) position steady in Q3 2026 at 110 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Cornerstone Financial Management first reported a position in BIOA in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.7K in Q2 2026. 162 funds tracked by Wall St. Rank hold BIOA as of Q3 2026.

  • Cornerstone Financial Management held 110 shares of BioAge Labs worth $780 as of Q3 2026.
  • Cornerstone Financial Management left its BioAge Labs share count unchanged in Q3 2026.
  • BioAge Labs made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q3 2026, its #1262 holding.
  • Cornerstone Financial Management first reported a position in BioAge Labs in Q4 2025 and has held it in 4 quarters since.
  • Cornerstone Financial Management's BioAge Labs position peaked at $2.7K in Q2 2026.
  • 162 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2026.

Based on Cornerstone Financial Management's 13F filing for Q3 2026, filed 10 Nov 2026.